THE ROLE OF NITRIC OXIDE IN ACUTE LUNG INJURY
一氧化氮在急性肺损伤中的作用
基本信息
- 批准号:6242252
- 负责人:
- 金额:$ 15.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-01 至 1997-11-30
- 项目状态:已结题
- 来源:
- 关键词:adult respiratory distress syndrome apoptosis biological signal transduction chemoprevention cytokine endothelin enzyme induction /repression human subject human therapy evaluation hydrogen peroxide inflammation isolation perfusion laboratory rabbit laboratory rat leukocyte activation /transformation leukocyte adhesion molecules nitric oxide nitric oxide synthase oxidizing agents oxygen tension platelet aggregation platelet derived growth factor respiratory therapy tumor necrosis factor alpha vascular endothelium
项目摘要
OBJECTIVE: The goal of this proposal is to determine the biochemical
mechanisms by which nitric oxide (NO) affects oxidant induced lung
injury.
HYPOTHESES: 1. We hypothesize that NO can play a pivotal role in
reducing oxidant lung injury by increasing cGMP, scavenging O2,
decreasing iron-mediated oxidant generation by chelating iron, or
inhibiting platelet and polymorphonuclear leukocyte (PMN) adherence and
activation. 2. Although NO generally plays a protective physiologic
role, we hypothesize that during dysregulated inflammatory events
increased levels of NO many augment or predispose the lung to oxidant
injury by inhibiting key iron containing intracellular enzymes and by
potentially generating OH from the interaction of NO and O2.
RESEARCH PLAN: The project will investigate molecular, biochemical and
physiologic interactions between reactive nitrogen intermediates and
reactive oxygen intermediates, emphasizing how these interactions might
ameliorate or augment lung injury. The first aim will determine the
effect of NO on oxidant injury in the isolated lung and in pulmonary
endothelial cells. These experiments will extend our preliminary
findings, which indicate a protective effect of NO under these
conditions, and will focus on investigating potential mechanisms. The
second aim will investigate the molecular and cellular regulation of
inducible NO synthase in lung endothelial and epithelial cells in
response to inflammatory modulators (TNFa, IFNy, and PDGF) and
physiological conditions (hypoxia and hyperoxia) present in ARDS
patients. In this aim we will also establish the relationship between
alterations in inducible enzyme. NO production and susceptibility to
oxidant injury. These experiments will test the hypothesis that
activation of inducible high output NO production cause metabolic changes
in pulmonary endothelial and epithelial cells that predispose them to
oxidant injury. The third aim investigates the cellular mechanisms by
which NO inhibits PMN adhesion to endothelial cells and PMN activation
in response to signaling molecules expressed by endothelial cells. The
fourth aim will determine the level of endogenous NO production in septic
patients, who are at risk for ARDS, and in patients with ARDS.
SIGNIFICANCE: The proposed research will provide a better understanding
of the conflicting roles that NO may play in preventing or promoting
oxidant lung injury. This is timely since NO is being promoted as an
investigational therapy in patients with ARDS.
目的:本方案的目的是确定生化指标。
一氧化氮影响氧化物性肺损伤的机制
受伤。
假设:1.我们假设NO在
增加cGMP,清除O2,减轻氧化性肺损伤
通过螯合铁来减少铁介导的氧化剂的生成,或者
抑制血小板和多形核白细胞(PMN)的黏附
激活。2.虽然一氧化氮通常起到保护生理的作用
角色,我们假设在失调的炎症事件中
NO水平的升高会增加或使肺易受氧化剂的影响
通过抑制关键含铁胞内酶和通过
潜在地从NO和O2的相互作用中产生OH。
研究计划:该项目将研究分子、生化和
活性氮中间体和活性氮中间体的生理相互作用
活性氧中间体,强调这些相互作用如何可能
改善或加重肺损伤。第一个目标将决定
一氧化氮在离体肺和肺组织氧化损伤中的作用
内皮细胞。这些实验将延长我们初步的
研究结果表明,在这些情况下,NO具有保护作用
条件,并将重点调查潜在的机制。这个
第二个目标将研究细胞和分子调控。
大鼠肺内皮细胞和上皮细胞诱导型一氧化氮合酶
对炎症调节剂(TNFa、IFNy和PDGF)的反应和
ARDS患者存在的生理状况(缺氧和高氧)
病人。在这一目标中,我们还将建立
诱导酶的变化。无生产和易感性
氧化损伤。这些实验将检验这一假设
可诱导的高产量NO产生的激活引起代谢变化
在肺内皮细胞和上皮细胞中,使它们容易发生
氧化损伤。第三个目的是研究细胞机制,通过
其中,NO抑制PMN与内皮细胞的黏附和PMN的激活
以响应内皮细胞表达的信号分子。这个
第四个目标将确定脓毒症患者内源性NO的产生水平
有ARDS风险的患者和ARDS患者。
意义:拟议的研究将提供更好的理解
NO在预防或促进中可能扮演的冲突角色
氧化性肺损伤。这是及时的,因为NO正在被宣传为
ARDS患者的探索性治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN R MICHAEL其他文献
JOHN R MICHAEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN R MICHAEL', 18)}}的其他基金
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 15.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 15.46万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 15.46万 - 项目类别:
Discovery Grants Program - Individual